人类关节软骨细胞产量、增殖及扩增后软骨生成能力的年龄相关变化。
Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity.
作者信息
Barbero Andrea, Grogan Shawn, Schäfer Dirk, Heberer Michael, Mainil-Varlet Pierre, Martin Ivan
机构信息
Department of Surgery, University Hospital, Basel, Switzerland.
出版信息
Osteoarthritis Cartilage. 2004 Jun;12(6):476-84. doi: 10.1016/j.joca.2004.02.010.
OBJECTIVE
We investigated how aging effects human chondrocyte yield, proliferation, post-expansion chondrogenic capacity, and response to specific growth factors supplemented during expansion.
METHODS
Fifty-two samples of human articular cartilage were harvested from cadavers 20 to 91 years old and grouped into age decades. Cell yields were normalised to tissue wet weight. Cell proliferation rates were calculated during expansion in medium without (CTR) or with TGF beta 1, FGF-2 and PDGF-BB (TFP). Chondrogenic capacity of CTR- and TFP-expanded cells was assessed by cultivation as 3D pellets in a defined serum-free medium, followed by histological, immunohistochemical, biochemical and real-time RT-PCR analyses.
RESULTS
Cell yields were similar in donors up to 40 years of age and significantly lower (1.8-fold) in older donors. Cell proliferation rates in CTR medium significantly decreased after 30 years of age and remained similar in older donors. In the presence of TFP, proliferation rates were higher (up to 3.7-fold) in all age groups and decreased only slightly with age. The glycosaminoglycan (GAG) content of pellets obtained from CTR-expanded cells was not correlated with age. Pellets from TFP-expanded cells reproducibly contained more GAG (up to 3.2-fold) than those from CTR-expanded cells only if donors were younger than 40. Safranin O staining intensity and collagen type II expression and accumulation were consistent with GAG contents.
CONCLUSION
Medium supplementation with the growth factor combination TFP during chondrocyte expansion supports higher proliferation rates at any age and higher post-expansion chondrogenic capacity in donors up to 40 years. These findings may be relevant for chondrocyte-based cartilage repair procedures.
目的
我们研究了衰老如何影响人软骨细胞的产量、增殖、扩增后的软骨形成能力以及对扩增过程中添加的特定生长因子的反应。
方法
从20至91岁的尸体上获取52份人关节软骨样本,并按年龄十年分组。细胞产量以组织湿重进行标准化。在无(CTR)或添加转化生长因子β1、碱性成纤维细胞生长因子-2和血小板衍生生长因子-BB(TFP)的培养基中扩增期间计算细胞增殖率。通过在限定的无血清培养基中培养为三维微球,然后进行组织学、免疫组织化学、生化和实时逆转录-聚合酶链反应分析,评估CTR和TFP扩增细胞的软骨形成能力。
结果
40岁及以下供体的细胞产量相似,而老年供体的细胞产量显著降低(1.8倍)。30岁以后,CTR培养基中的细胞增殖率显著下降,老年供体的细胞增殖率保持相似。在TFP存在的情况下,所有年龄组的增殖率都更高(高达3.7倍),并且仅随年龄略有下降。从CTR扩增细胞获得的微球中的糖胺聚糖(GAG)含量与年龄无关。仅当供体年龄小于40岁时,TFP扩增细胞的微球中GAG含量可重复性地比CTR扩增细胞的微球多(高达3.2倍)。番红O染色强度以及II型胶原表达和积累与GAG含量一致。
结论
在软骨细胞扩增过程中用生长因子组合TFP补充培养基,可支持任何年龄的较高增殖率以及40岁及以下供体扩增后的较高软骨形成能力。这些发现可能与基于软骨细胞的软骨修复程序相关。